[ad_1] LINDAU, GERMANY: A new anti-tuberculosis drug for the treatment of multidrug-resistant tuberculosis (MDRTB) may not be without side effects and governments should be cautious when administering the drug, said Sir John …
Read More »[ad_1] LINDAU, GERMANY: A new anti-tuberculosis drug for the treatment of multidrug-resistant tuberculosis (MDRTB) may not be without side effects and governments should be cautious when administering the drug, said Sir John …
Read More »